1. Wang W, Jiang B, Sun H, Ru X, Sun D, Wang L, et al. Prevalence, Incidence, and Mortality of Stroke in China: Results from a Nationwide Population-Based Survey of 480 687 Adults. Circulation. 2017;135 8:759 − 71; doi: 10.1161/circulationaha.116.025250.
2. Ling X, Yan SM, Shen B, Yang X. A modified Essen Stroke Risk Score for predicting recurrent ischemic stroke at one year. Neurological research. 2018;40 3:204 − 10; doi: 10.1080/01616412.2018.1428389.
3. Boysen G, Truelsen T. Prevention of recurrent stroke. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2000;21 2:67–72.
4. Wang Y, Xu J, Zhao X, Wang D, Wang C, Liu L, et al. Association of hypertension with stroke recurrence depends on ischemic stroke subtype. Stroke. 2013;44 5:1232-7; doi: 10.1161/STROKEAHA.111.000302.
5. Wang YL, Pan YS, Zhao XQ, Wang D, Johnston SC, Liu LP, et al. Recurrent stroke was associated with poor quality of life in patients with transient ischemic attack or minor stroke: finding from the CHANCE trial. CNS neuroscience & therapeutics. 2014;20 12:1029-35; doi: 10.1111/cns.12329.
6. Erdur H, Scheitz JF, Ebinger M, Rocco A, Grittner U, Meisel A, et al. In-hospital stroke recurrence and stroke after transient ischemic attack: frequency and risk factors. Stroke. 2015;46 4:1031-7; doi: 10.1161/STROKEAHA.114.006886.
7. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45 7:2160 − 236; doi: 10.1161/STR.0000000000000024.
8. Association CSoNoCM. Guidelines for Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack in China 2014 Chinese Journal of Neurology. 2015;48 4:258 − 73; doi: 10.3760/cma.j.issn.1006-7876.2015.04.003.
9. Committee CS. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348 9038:1329-39; doi: 10.1016/s0140-6736(96)09457-3.
10. Ringleb PA, Bhatt DL, Hirsch AT, Topol EJ, Hacke W, Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events I. Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events. Stroke. 2004;35 2:528 − 32; doi: 10.1161/01.STR.0000110221.54366.49.
11. Bhatt DL, Marso SP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ. Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. The American journal of cardiology. 2002;90 6:625-8.
12. Ferreiro JL, Bhatt DL, Ueno M, Bauer D, Angiolillo DJ. Impact of smoking on long-term outcomes in patients with atherosclerotic vascular disease treated with aspirin or clopidogrel: insights from the CAPRIE trial (Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events). Journal of the American College of Cardiology. 2014;63 8:769 − 77.
13. Weimar C, Diener HC, Alberts MJ, Steg PG, Bhatt DL, Wilson PW, et al. The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of Atherothrombosis for Continued Health (REACH) registry. Stroke. 2009;40 2:350-4.
14. Xu H, Ping Y, Lin H, He P, Li W, Dai H. Antiplatelet Strategies and Outcomes in Patients with Noncardioembolic Ischemic Stroke from a Real-World Study with a Five-Year Follow-Up. Translational stroke research. 2017;8 3:228 − 33; doi: 10.1007/s12975-016-0516-0.
15. Chin YY, Sakinah H, Aryati A, Hassan BM. Prevalence, risk factors and secondary prevention of stroke recurrence in eight countries from south, east and southeast asia: a scoping review. The Medical journal of Malaysia. 2018;73 2:90 − 9.
16. Association NBOC. China Guideline for Diagnosis and Treatment of Acute Ischemic Stroke(2010) Chinese Journal of Neurology. 2010;43 2:146 − 53; doi: 10.3969/j.issn.1674-7372.2010.04.012.
17. Diener HC, Ringleb PA, Savi P. Clopidogrel for the secondary prevention of stroke. Expert opinion on pharmacotherapy. 2005;6 5:755 − 64.
18. Amos A. Women and smoking. British medical bulletin. 1996;52 1:74–89; doi: 10.1093/oxfordjournals.bmb.a011534.
19. Chen P, Liu Y, Wang Y, Wang A, Zheng H, Zhao X, et al. A Validation of the Essen Stroke Risk Score in Outpatients with Ischemic Stroke. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2016;25 9:2189-95; doi: 10.1016/j.jstrokecerebrovasdis.2016.02.001.
20. Desai NR, Mega JL, Jiang S, Cannon CP, Sabatine MS. Interaction between cigarette smoking and clinical benefit of clopidogrel. Journal of the American College of Cardiology. 2009;53 15:1273-8; doi: 10.1016/j.jacc.2008.12.044.
21. COMMUNICATIONS F, PUBLIC AWARENESS/ADVOCACY SSO: World Stroke Congress Abstracts, 2018. In: World Stroke Congress. 2018.
22. Xu G, Liu X, Wu W, Zhang R, Yin Q. Recurrence after ischemic stroke in chinese patients: impact of uncontrolled modifiable risk factors. Cerebrovascular diseases. 2007;23 2–3:117 − 20; doi: 10.1159/000097047.
23. Kaplan RC, Tirschwell DL, Longstreth WT, Jr., Manolio TA, Heckbert SR, Lefkowitz D, et al. Vascular events, mortality, and preventive therapy following ischemic stroke in the elderly. Neurology. 2005;65 6:835 − 42; doi: 10.1212/01.wnl.0000176058.09848.bb.